Description
PRAME (Preferentially Expressed Antigen in Melanoma) is a nuclear protein that functions as a tumor-associated antigen and is classified as a cancer-testis antigen. It is expressed in a wide range of malignant tumors including melanoma, non-small cell lung cancer, breast carcinoma, ovarian carcinoma, renal cell carcinoma, and various sarcomas, while remaining largely absent in normal adult tissues—with the exception of testis, ovary, adrenal, and endometrium.
The PRAME antibody (clone EPR20330) offers high sensitivity and specificity for immunohistochemical detection of PRAME expression in formalin-fixed, paraffin-embedded (FFPE) tissue samples. It is particularly valuable in differentiating malignant melanoma from benign nevi and in identifying tumors with potential immunotherapeutic relevance. Nuclear staining provides a clear, interpretable pattern to aid diagnostic confidence.
This prediluted format is optimised for use with standard IHC protocols and is ready to use without additional dilution.
Specifications
Intended Use
IVD
Format
Predilute
Volume
6.0 mL
Source
Rabbit Monoclonal
Clone
EPR20330
Isotype
IgG
Antigen
PRAME protein, encoded on chromosome 22q11.22
Localization
Nuclear
Positive Control
Melanoma or testicular tissue
Species Reactivity
Human

![PRAME [EPR20330] 6ML](https://www.mediscope.co.nz/wp-content/uploads/images-1.jpg)



